-
Screening for chromosomal abnormalities at 10-14 weeks: the role of ductus venosus blood flow.
Matias A, Gomes C, Flack N, Montenegro N, Nicolaides KH.
Ultrasound Obstet Gynecol 1998;12:380-4. -
The umbilical artery pulsatility index in the first trimester: is there an association with increased nuchal translucency or chromosomal abnormality?
Brown R, Di Luzio L, Gomes C, Nicolaides KH.
Ultrasound Obstet Gynecol 1998;12:244-7. -
Fetal nuchal translucency thickness at 10-14 weeks gestation and congenital diaphragmatic hernia.
Sebire NJ, Snijders RJ, Davenport M, Greenough A, Nicolaides KH.
Obstet Gynecol 1997;90:943-6. -
Management of twin pregnancies with fetal trisomies.
Sebire NJ, Snijders RJM, Santiago C, Papapanagiotou G, Nicolaides KH.
BJOG 1997;104:220-2. -
Fetal heart rate at 10-14 weeks and birthweight.
Sebire NJ, Nayar R, Carvalho M, Soares W, Nicolaides KH.
BJOG 1997;104:1207-9. -
Maternal serum free beta-hCG at 10 to 14 weeks of gestation in trisomic twin pregnancies.
Noble PL, Snijders RJ, Abraha HD, Sherwood RA, Nicolaides KH.
BJOG 1997;104:741-3. -
Urinary beta-core hCG: screening for aneuploidies in early pregnancy (11-14 weeks gestation)
Macintosh MC, Nicolaides KH, Noble P, Chard T, Gunn L, Illes R.
Prenat Diagn 1997;17:401-5. -
Increased nuchal translucency at 10-14 weeks of gestation as a marker for major cardiac defects.
Hyett JA, Perdu M, Sharland GK, Snijders RSM, Nicolaides KH.
Ultrasound Obstet Gynecol 1997;10:242-6. -
First-trimester ultrasound screening for chromosomal defects.
Snijders RJ, Johnson S, Sebire NJ, Noble PL, Nicolaides KH.
Ultrasound Obstet Gynecol 1996;7:216-26. -
Fetal megacystis at 10-14 weeks of gestation.
Sebire NJ, Von Kaisenberg C, Rubio C, Nicolaides KH.
Ultrasound Obstet Gynecol 1996;8:387-90. -
Fetal karyotyping in twin pregnancies: selection of technique by measurement of fetal nuchal translucency.
Sebire NJ, Noble PL, Psarra A, Papapanagiotou G, Nicolaides KH.
BJOG 1996;103:887-90. -
Comparison of chorion villus sampling and early amniocentesis for karyotyping in 1,492 singleton pregnancies.
Nicolaides KH, Brizot ML, Patel F, Snijders R.
Fetal Diagn Ther 1996;11:9-15. -
Total amount of circulating human chorionic gonadotrophin alpha and beta subunits in first trimester trisomies 21 and 18.
Jauniaux E, Nicolaides KH, Nagy AM, Brizot M, Meuris S.
J Endocrinol 1996;148:27-31. -
Fetal heart rate and umbilico-placental Doppler flow velocity waveforms in early pregnancies with a chromosomal abnormality and/or an increased nuchal translucency thickness.
Jauniaux E, Gavrill P, Kuhn P, Kurdi W, Hyett J, Nicolaides KH.
Hum Reprod 1996;11:435-9. -
Fetal heart rate in trisomy 21 and other chromosomal abnormalities at 10-14 weeks of gestation.
Hyett JA, Noble PL, Snijders RJ, Montenegro N, Nicolaides KH.
Ultrasound Obstet Gynecol 1996;7:239-44. -
Abnormatlities of the heart and great arteries in chromosomally normal fetuses with increased nuchal translucency thickness at 11-13 weeks of gestation.
Hyett J, Moscoso G, Papapanagiotou G, Perdu M, Nicolaides KH.
Ultrasound Obstet Gynecol 1996;7:245-50. -
Fetal hepatic alpha-fetoprotein mRNA expression in fetuses with trisomy 21 and 18 at 12-15 weeks gestation.
Brizot ML, Mckie AT, von-Kaisenberg CS, Farzaneh F, Nicolaides KH.
Early Hum Dev 1996;44:155-9. -
Gene expression of human pregnancy-associated plasma protein-A in placenta from trisomic pregnancies.
Brizot ML, Hyett JA, Mckie AT, Bersinger NA, Farzaneh F, Nicolaides KH.
Placenta 1996;17:33-6. -
Maternal platelet size as a marker for fetal trisomies 18 and 13.
Thilaganathan B, Meher-Homji NJ, Nicolaides KH.
Prenat Diagn 1995;15:605-8. -
Blood transferrin receptor expression in chromosomally abnormal fetuses.
Thilaganathan B, Meher-Homji NJ, Nicolaides KH.
Prenat Diagn 1995;15:282-4.